Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | KU 0060648 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | RG-108 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | BRD-K51490254 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | selumetinib:piperlongumine (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | BRD-K17060750 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | BRD-K34485477 | CTRPv2 | pan-cancer | AAC | 0.031 | 0.7 |
mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | -0.018 | 0.7 |
mRNA | lomeguatrib | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | SMER-3 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | BRD-K26531177 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |